Pursuing New Business Areas Through Magnesium Alloys and Overseas Operations
First written in FY2016. 6 of 13 entries say "Restated". Latest entry: FY2026.
No other company in this theme has enough history to compare yet.
- FY2026RestatedAnnual report
「Bioresorbable magnesium alloys are being produced using the company's in-house integrated manufacturing and supply facilities covering material production through processing (melting and casting → extrusion → drawing). The company is working with research institutions and medical device developers to promote the practical application of medical devices.」
The company continues to pursue the practical application of medical and bioresorbable magnesium alloys through its in-house integrated facilities and collaboration with research institutions and medical device developers. - 2026-06-03AdvancedGeneral Meetings of Shareholders
「We will also continue research and development toward the practical application of medical magnesium alloys.」
The business-specific strategy explicitly states a policy of continuing research and development toward the practical application of medical magnesium alloys. - FY2025RestatedAnnual report
「At the same time, we will advance research and development toward the commercialization of medical magnesium alloys.」
The company continues to pursue a research and development policy aimed at the commercialization of medical magnesium alloys. - FY2024RestatedAnnual report
「In the Magnesium Business, we will promote research and development centered on medical magnesium.」
In the Magnesium Business, the company continues to pursue a research and development policy centered on medical magnesium. - FY2023AdvancedAnnual report
「Bioresorbable magnesium alloys, which are expected to serve as a base material for medical devices, are being produced using the company's in-house integrated manufacturing and supply facilities covering material production through processing (melting and casting → extrusion → drawing). The company is working with research institutions and medical device developers to promote the practical application of medical devices.」
In the Magnesium Business, the company is at the stage of advancing practical application using in-house integrated manufacturing facilities for bioresorbable alloys, together with research institutions and medical device developers. - FY2020RestatedAnnual report
「In the Magnesium Business, we will promote joint development with industry, academia and government agencies from a medium- to long-term perspective.」
In the Magnesium Business, joint development by industry, academia and government agencies continues as a medium- to long-term initiative. - FY2019AdvancedAnnual report
「For flame-retardant magnesium alloys, the company advanced the development of materials for high-speed railcars under the “Innovative Development of New Structural Materials and Related Technologies” project and successfully produced a prototype of a high-speed railcar partial body structure, 1 m in length, using one of the world's largest flame-retardant magnesium alloys.」
In the Magnesium Business, the company successfully produced a prototype of a partial high-speed railcar body structure and introduced integrated facilities covering the process from melting and casting through extrusion and drawing for bioresorbable magnesium alloys. In the Overseas Business, it is strengthening orders in the ASEAN region, centered on Vietnam and the Philippines. - FY2018AdvancedAnnual report
「Bioresorbable magnesium alloys, which are expected to serve as a base material for medical devices, were selected for NEDO's “Bridging Research and Development Promotion Project for Mid-sized and Small Enterprises.” The company established and introduced the world's first integrated research and development facilities covering casting, extrusion, drawing and inspection.」
In the Magnesium Business, the company progressed to the stage of establishing and introducing integrated research and development facilities for bioresorbable alloys following its selection for a NEDO project. - FY2017ReframedAnnual report
「In the Overseas Business, we will focus on Vietnam, the Philippines and other ASEAN countries, as well as Taiwan, as target regions, reliably execute projects for which we have received orders, and establish an overseas business model. In the Magnesium Business, we will work to build a foundation for supplying new alloys to specialized fields where the properties of magnesium alloys can be utilized.」
The Overseas Business has been reorganized from its previous broad-based sales expansion policy to focus on the ASEAN region, including Vietnam and the Philippines, as well as Taiwan, with the aim of building a business model. The Magnesium Business has also established a focus on supplying specialized fields. - FY2017-Q3RestatedAnnual report
「Against this backdrop, our Group formulated the Medium-Term Management Plan “Leap Forward” (fiscal 2014–2016), adopting “achieving value innovation,” “building a resilient business system,” “strengthening growth areas,” and “taking on challenges in new fields” as its basic strategies, and is working as one across the Group to achieve the plan’s goals.」
Taking on new fields continues as a basic strategy under the medium-term management plan. Separately, the Extruded Products Sales Business continues to refer to the contraction of overseas operations. - FY2017-Q2RestatedAnnual report
「The Group formulated the “Leap Forward” medium-term management plan (fiscal 2014–fiscal 2016), adopted “achieving value innovation,” “building a robust business system,” “strengthening growth fields” and “taking on new fields” as its basic strategies, and is working as one across all Group companies.」
While taking on new fields continues as a basic strategy, descriptions of the business situation continue to refer to the contraction of overseas operations. - FY2017-Q1SoftenedAnnual report
「Although the business environment surrounding the Group has become more challenging due to the contraction of the Overseas Business and fluctuations in material prices, the Group will continue to work as one under its basic strategies of “achieving value innovation,” “building a robust business system,” “strengthening growth fields” and “taking on new fields.”」
The focus has shifted from the previous direction of expanding the Overseas Business and forming alliances with local companies to the contraction of the Overseas Business. Meanwhile, taking on new fields itself continues as a basic strategy. - FY2016First statedAnnual report
「③Taking on new fields, including joint development of applications with various industries in the New Materials Business (magnesium alloys), expansion of sales of products under the Fuji brand in the Overseas Business, and alliances with local companies,」
The company has identified joint development of applications for magnesium alloys, expansion of its brand overseas, and partnerships with local companies as its means of execution.